A
5.22
0.16 (3.16%)
| Penutupan Terdahulu | 5.06 |
| Buka | 5.12 |
| Jumlah Dagangan | 204,863 |
| Purata Dagangan (3B) | 500,557 |
| Modal Pasaran | 1,626,557,952 |
| Harga / Pendapatan (P/E TTM) | 22.70 |
| Harga / Pendapatan (P/E Ke hadapan) | 9.52 |
| Harga / Jualan (P/S) | 2.33 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| Margin Keuntungan | 16.42% |
| Margin Operasi (TTM) | 7.97% |
| EPS Cair (TTM) | 0.370 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 260.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -65.50% |
| Nisbah Semasa (MRQ) | 1.73 |
| Aliran Tunai Operasi (OCF TTM) | -148.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -216.76 M |
| Pulangan Atas Aset (ROA TTM) | 7.02% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menaik | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Bercampur | |
| Stok | Alvotech | Menurun | Menurun |
AISkor Stockmoo
1.3
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.5 |
| Purata | 1.25 |
|
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 63.44% |
| % Dimiliki oleh Institusi | 6.44% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Lodbrok Capital Llp | 30 Sep 2025 | 181,587 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 14.00 (Morgan Stanley, 168.20%) | Beli |
| Median | 10.00 (91.57%) | |
| Rendah | 8.00 (Deutsche Bank, 53.26%) | Pegang |
| Purata | 10.67 (104.41%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 6.15 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| UBS | 18 Nov 2025 | 10.00 (91.57%) | Beli | 5.11 |
| Deutsche Bank | 04 Nov 2025 | 8.00 (53.26%) | Pegang | 4.83 |
| 23 Sep 2025 | 14.00 (168.20%) | Beli | 8.70 | |
| Morgan Stanley | 14 Oct 2025 | 14.00 (168.20%) | Beli | 8.50 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |